References
- J. Med. Chem. v.6 T. P. Johnston;G. S. McCaleb;J. A. Montgomery
- J. Med. Chem. v.15 F. I. Carroll;A. Philip;J.T. Blackwell;D. J. Taylor;M. E. Wall
- J. Med. Chem. v.22 H-Y. P. Lam;A. Begleiter;G. J. Galdenberg;C. H. Wong
- Arch. Pharm. Res. v.9 J. C. Kim;S. K. Choi;S. H. Moon
- Yakhak Hoeji v.29 J. C. Kim;I. S. Choi;D. S. Yu;S. H. Ryu;K. H. Moon
- J. Org. Chem. v.26 N. J. Doorenbos;L. C. Huang
- J. Pharm. Sci. v.63 N. J. Doorenbos;J. C. Kim
- J. Med. Chem. v.9 T. P. Johnston;G. S. McCaleb;P. S. Oliger;J. A. Montgomery
Cited by
- ChemInform Abstract: Synthesis of 4-Aza-cholestane Derivatives Containing Nitrosoureido Function as Antitumor Activity. vol.24, pp.46, 1993, https://doi.org/10.1002/chin.199346213
- Preparation of N'-Substituted Anilino-N-Methyl-N-Nitorsoureas as Candidate Antitumor Agents vol.17, pp.6, 1993, https://doi.org/10.1007/bf02979118
-
Synthesis and antitumor evaluation of
$\alphamethylene-\gamma-butyrolactone-linked$ to 5-substituted uracil nucleic acid bases vol.19, pp.3, 1996, https://doi.org/10.1007/bf02976897 - Potential Antitumor ${\alpha}$-methylene-${\gamma}$-butyrolactone-bearing nucleic acid bases. 2. synthesis of $5^I-Methyl-5^I$-[2-(5-substituted uracil-1-yl)ethyl]-$2^I-oxo-3^I$-methylenetetrahydrofur vol.20, pp.3, 1993, https://doi.org/10.1007/bf02976153
- Potential Antitumor $\alpha$-Methylene-$\gamma$-butyrolactone-Bearing Nucleic Acid Base. 3. Synthesis of $5^1$-Methyl-$5^1$-[(6-substituted-9H-purin-9-yl)methyl]-$2^1$-oxo-$3^1$-methylenetetrahydrofur vol.21, pp.4, 1993, https://doi.org/10.1007/bf02974643